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Female Patient Showing Hypohidrotic Ectodermal
Dysplasia and Immunodeficiency (HED-ID)
To the Editor:
Amorphic mutations of the NEMO gene (Smahi et al.
2000) lead to incontinentia pigmenti (IP [MIM
308300]), an X-linked dominant disorder in which het-
erozygous female patients exhibit skin lesions along the
Blaschko lines, cicatrization of the retina, and hypo-
dontia (Landy and Donnai 1993). The majority of hemi-
zygous male fetuses die in utero. In the December 2000
issue of the Journal, Zonana et al. (2000) reported that
hypomorphic mutations in the NEMO gene lead to an
apparently novel X-linked recessive entity, hypohidrotic
ectodermal dysplasia and immunodeficiency (HED-ID).
HED-ID is characterized by features—ectodermal dys-
plasia and recurrent infections accompanied by dysgam-
maglobulinemia—distinct from those of IP. Zonana et
al. (2000) stated that HED-ID affects only males and
that female heterozygotes do not exhibit clinical mani-
festations of immunodeficiency. Independently of Zon-
ana et al., in the March issue of the Journal, Aradhya
et al. (2001) reported that hypomorphic mutations in
NEMO lead to an “atypical form of IP in males” whose
clinical features, including immunodeficiency, overlap
those of HED-ID. We report a female patient with fea-
tures of HED-ID and a heterozygous hypomorphic
NEMOmutation to show that female heterozygotes can
be overtly affected and that the wide phenotypic spec-
trum of female heterozygotes should be taken into ac-
count when counseling families with HED-ID.
The proband presented with hyperpigmented macules
in a streaky configuration on the trunk and extremities
at age 3 wk. Histologic examination revealed irregular
basal melanosis and a slight increase in the number of
melanocytes in the epidermis, but there was no evidence
of the pigmentary incontinence typically observed in IP.
The areas of skin involvement stabilized by age 5 mo. At
that time, the proband and the mother had been reported
as the first familial cases of “linear and whorled nevoid
hypermelanosis” (Akiyama et al. 1994). At 4 years of age,
the patient began to experience recurrent infections, in-
cluding respiratory-tract infections, cervical lymphade-
nitis, otitis media, cellulitis, and soft-tissue abscesses. The
patient had a history of chronic lung infections with sec-
ondary bronchiectasis and pulmonary hypertension at 8
years of age and developed renovascular hypertension at
10 years of age. Immunoglobulin determinations at age
10 years showed abnormally high levels of IgD, 1,520
mg/dL (normal range 1.8–8.5 mg/dL), and IgE levels el-
evated to 17,600 IU/mL (normal range !250 IU/mL). At
11 years of age, she exhibited eczematous, dry skin with
hyperpigmentation along the Blaschko lines; decreased
sweating; periorbital wrinkling of the skin; thin scalp hair
and sparse eyebrows; conical incisors; and hypodontia
with four permanent teeth missing. The patient died
shortly after cardiac catheterization at 11 years of age.
The proband’s mother manifested hyperpigmented mac-
ules in a streaky configuration on the trunk and the ex-
tremities at several weeks of age. The mother, 44 years
of age, never developed clinical manifestations of im-
munodeficiency. The younger sister of the proband de-
veloped hyperpigmentation along the Blaschko lines in
infancy but is otherwise healthy at 7 years of age.
After obtaining informed consent, a genomic DNA
sample from the proband’s peripheral blood leukocytes
was examined. Direct sequencing of the entire coding
region of the NEMO gene (Smahi et al. 2000) revealed
insertion of a cytosine (dupC1161) within a wild-type
run of seven cytosines. This insertion resulted in a novel
amino acid at codon 390–393 and a premature stop at
codon 394. This mutation truncates the protein and de-
leted a putative zinc-finger domain. X-inactivation anal-
ysis of the proband’s peripheral blood leukocytes based
on the methylation status of the androgen-receptor gene
(Parrish et al. 1996) revealed that the normal and the
mutated chromosomes were randomly inactivated. We
were unable to performmolecular analyses of themother
and the younger sister.
The dupC1161 mutation has been documented in
three other pedigrees (Zonana et al. 2000; Aradhya et
al. 2001). The phenotypic spectrum of the obligate car-
rier females in these families, including the one in this
report, is very broad: HED-ID in the proband of the
family described here, linear and whorled skin hyper-
pigmentation in the mother and the younger sister, “typ-
ical IP skin-pigmentation and retinal abnormalities” in
families XL267 and XL344 (Aradhya et al. 2001), and
“normal” (HED-ID-4, II-2; Zonana et al. 2000).
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Variable phenotype in females with the samemutation
could be explained by variations in expression due to
differences in X inactivation among families, as sug-
gested by Aradhya (2000). If so, an X-inactivation study
could be helpful in predicting phenotypic outcome in a
female heterozygote with the mutation. However, the
proband in the family described here (HED-ID pheno-
type) and the female heterozygote in family XL344 (IP-
like phenotype; Aradhya et al. 2001) yielded the same
random X-inactivation pattern. We therefore suspect
that an X-inactivation study would have limited predic-
tive value.
To summarize, hypomorphic mutations in theNEMO
gene can lead to the devastating HED-ID phenotype in
female heterozygotes as well as males. The very broad
phenotypic spectrum of female heterozygotes, ranging
from normal to overt immunodeficiency, poses a chal-
lenge during counseling of families with HED-ID.
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Reply to Kosaki et al.
To the Editor:
The letter from Kosaki et al. (2001 [in this issue]) reports
the first instance of immunodeficiency in a female het-
erozygous for a hypomorphic mutation of the X-linked
NEMO gene. NEMO hypomorphic mutations result, in
males, in the disorder hypohidrotic ectodermal dysplasia
with immunodeficiency (HED-ID) (Zonana et al. 2000;
Aradhya et al. 2001; Doffinger et al. 2001; Jain et al.
2001). In the 17 families previously reported, only males
have had clinical immunodeficiency. As expected, owing
to Lyonization, carrier females either were normal or
had defects of their teeth, skin, or hair. A single female
carrier, heterozygous for the same mutation reported in
the family studied by Kosaki et al., had an elevated im-
munoglobulin A level (Zonana et al. 2000) but did not
have immunodeficiency.
Null mutation of the NEMO gene generally results in
prenatal lethality in hemizygous males and in inconti-
nentia pigmenti in heterozygous females. Affected fe-
males are immunologically normal, presumably owing
to preferential survival and proliferation of cells ex-
pressing the normal allele (skewed X inactivation). Fe-
male carriers with hypomorphic mutations have shown
both random and skewed X inactivation, indicating that
at least some of the mutations do not affect T- and B-
cell survival or proliferation (Aradhya et al. 2001; Dof-
finger et al. 2001; Jain et al. 2001). Rarely, females can
fully manifest X-linked recessive disorders, including
other X-linked immunodeficiencies, such as Wiskott-Al-
